Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gottstein

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Protein Engineering|December 7, 2002
Affinity chromatography system for parallel purification of recombinant protein samplesC Gottstein, R Forde
Biotechniques|November 26, 1999
In vivo measurement of biodistribution kinetics of radiolabeled compounds in laboratory animalsC Gottstein, R Forde
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2005
Targeting of immunoliposomes to endothelial cells expressing VCAM: a future strategy in cancer therapyS Gosk, C Gottstein, G Bendas
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 12, 2003
[Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?]A M Joussen, B Kirchhof, C Gottstein
Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Anti-angiogenesis: a new approach to tumor therapy?]D Schiefer, C Gottstein, V Diehl, et al.
Biotechniques|February 24, 2001
Generation and characterization of recombinant vascular targeting agents from hybridoma cell linesC Gottstein, W Wels, B Ober, et al.
Biochemical and Biophysical Research Communications|December 5, 1998
Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonanceX Huang, C Gottstein, R A Brekken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Immunotoxins: is there a clinical value?C Gottstein, U Winkler, H Bohlen, et al.
Leukemia & Lymphoma|May 1, 1994
Experimental treatment of human Hodgkin's disease with ricin A-chain immunotoxinsA Engert, C Gottstein, U Winkler, et al.
Medizinische Klinik (Munich, Germany : 1983)|October 15, 1992
[New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?]A Engert, C Gottstein, U Winkler, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Protein Engineering|December 7, 2002
Affinity chromatography system for parallel purification of recombinant protein samplesC Gottstein, R Forde
Biotechniques|November 26, 1999
In vivo measurement of biodistribution kinetics of radiolabeled compounds in laboratory animalsC Gottstein, R Forde
International Journal of Clinical Pharmacology and Therapeutics|December 24, 2005
Targeting of immunoliposomes to endothelial cells expressing VCAM: a future strategy in cancer therapyS Gosk, C Gottstein, G Bendas
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|April 12, 2003
[Molecular mechanisms of vasculogenesis and angiogenesis. What regulates vascular growth?]A M Joussen, B Kirchhof, C Gottstein
Medizinische Klinik (Munich, Germany : 1983)|November 11, 1999
[Anti-angiogenesis: a new approach to tumor therapy?]D Schiefer, C Gottstein, V Diehl, et al.
Biotechniques|February 24, 2001
Generation and characterization of recombinant vascular targeting agents from hybridoma cell linesC Gottstein, W Wels, B Ober, et al.
Biochemical and Biophysical Research Communications|December 5, 1998
Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonanceX Huang, C Gottstein, R A Brekken, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Immunotoxins: is there a clinical value?C Gottstein, U Winkler, H Bohlen, et al.
Leukemia & Lymphoma|May 1, 1994
Experimental treatment of human Hodgkin's disease with ricin A-chain immunotoxinsA Engert, C Gottstein, U Winkler, et al.
Medizinische Klinik (Munich, Germany : 1983)|October 15, 1992
[New perspectives in oncology: is selective destruction of tumor cells with immunotoxins in Hodgkin's disease an additional therapeutic alternative?]A Engert, C Gottstein, U Winkler, et al.
Pageof 2